Margaret Burroughs - Concepedia

Author

Margaret Burroughs

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Doerthe Eckert, M Burroughs, M H Burroughs, M. Burroughs, M. H. Burroughs, M.H. Burroughs, MARGARET BURROUGHS, Margaret Burroughs, Margaret H Burroughs, Margaret H. Burroughs

118

Publications

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)AbbVie (United States)Cedars-Sinai Medical Center Rockefeller University Toranomon Hospital

About

Margaret Burroughs is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, viral hepatitis, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	35	2.4K
2	Epidemiology	6	6	382
3	Health Sciences	1	1	12
4	Natural Sciences	1	1	290
5	Public Health	1	1	40

Margaret Burroughs

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection Bruce R. Bacon, Stuart C. Gordon, Eric Lawitz, New England Journal of Medicine	2011	1.6K
Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells Sue E. Crawford, Marie Labbé, J. Cohen, Journal of Virology Virus StructureMolecular VirologyInsect VirusInsect CellsNatural Sciences	1994	290
Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Jane M. Tramontana, Utaiwan Utaipat, Anthony G. Molloy, PubMed	1995	241
Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy Thierry Poynard, Massimo Colombo, Jordi Bruix, Gastroenterology Hepatitis C WhoHepatologyHepatitis CInterferon Alfa/ribavirin TherapyViral Hepatitis	2009	234
Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. Kapo Saukkonen, Carmen Cabellos, Margaret Burroughs, The Journal of Experimental Medicine Host ResponseMicrobial PathogensLung InflammationBordetella PertussisMedicine	1991	195
Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir Fred Poordad, Jean–Pierre Bronowicki, Stuart C. Gordon, Gastroenterology Viral PersistenceHepatitis CViral HepatitisAntiviral TherapyHepatitis	2012	193
Thalidomide Treatment Reduces Tumor Necrosis Factor α Production and Enhances Weight Gain in Patients with Pulmonary Tuberculosis Jane M. Tramontana, Utaiwan Utaipat, Anthony G. Molloy, Molecular Medicine Pulmonary TuberculosisImmunologyEnhances Weight GainTuberculosisMedicine	1995	191
Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b–infected Japanese patients with or without cirrhosis Hiromitsu Kumada, Kazuaki Chayama, Lino Rodrigues, Hepatology	2015	153
Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1–6 and compensated cirrhosis: The EXPEDITION-8 trial Robert S. Brown, Lino Rodrigues, Vladimir Chulanov, Journal of Hepatology	2019	151
CMV-IVIG for Prevention of Epstein Barr Virus Disease and Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant Recipients M. Green, Marian G. Michaels, Ben Z. Katz, American Journal of Transplantation Transplant RejectionPosttransplant Lymphoproliferative DiseaseTransplantationHepatologySolid Organ Transplantation	2006	117

Page 1